RT info:eu-repo/semantics/article
T1 Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
A1 Towns, Clodagh
A1 Richer, Madeleine
A1 Jasaityte, Simona
A1 Stafford, Eleanor J.
A1 Joubert, Julie
A1 Antar, Tarek
A1 Martínez Carrasco, Alejandro
A1 Makarious, Mary B.
A1 Casey, Bradford
A1 Vitale, Dan
A1 Levine, Kristin
A1 Leonard, Hampton
A1 Pantazis, Caroline B.
A1 Screven, Laurel A.
A1 Hernández, Dena G.
A1 Wegel, Claire E.
A1 Solle, Justin
A1 Nalls, Mike A.
A1 Blauwendraat, Cornelis
A1 Singleton, Andrew B.
A1 Tan, Manuela M. X.
A1 Iwaki, Hirotaka
A1 Morris, Huw R.
A1 Cubo Delgado, Esther
A1 Global Parkinson's Genetics Program
K1 Sistema nervioso-Enfermedades
K1 Nervous system-Diseases
K1 Medicina
K1 Medicine
K1 Neurología
K1 Neurology
AB The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.
PB Springer Nature
YR 2023
FD 2023-09
LK http://hdl.handle.net/10259/8851
UL http://hdl.handle.net/10259/8851
LA eng
DS Repositorio Institucional de la Universidad de Burgos
RD 08-may-2024